Idiopathic Thrombocytopenic Purpura in Patients with Ischaemic Heart Disease - A Therapeutic Challenge
Idiopathic thrombocytopenic purpura (ITP) and myocardial infarction (MI) in an individual patient is a rare combination. MI mandates thrombolytic and antiplatelet therapy which increases the risk of bleeding in ITP. So far, no guideline deals with management protocol for ischaemic heart disease (IHD) in ITP patients. Here, we describe 2 cases of IHD who developed ITP while on antiplatelet therapy.
Bangladesh Heart Journal 2018; 33(1) : 74-77
Copyright (c) 2018 Bangladesh Cardiac Society
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
© Bangladesh Cardiac Society.
Articles in the Bangladesh Heart Journal are Open Access articles published under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). This license permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.